Evidence check: Transferrin in the context of sleep

Transferrin is an iron-transport protein and a classic marker of iron metabolism. A direct, causal link between transferrin levels and sleep quality is not robustly established in the literature. However, iron deficiency – which can manifest as low transferrin saturation – is associated with Restless Legs Syndrome (RLS) and consequent sleep disturbances. The evidence comes from observational studies and clinical case series, not from randomized controlled trials that validate transferrin as an independent sleep predictor. Moreover, transferrin is influenced by many factors (inflammation, liver function, hormones), complicating its interpretation in a sleep context. Isolated case reports or small studies on ferritin and RLS are more common, but transferrin alone is rarely used as a primary biomarker for sleep issues. From a precision medicine perspective, it is premature to derive direct sleep recommendations from a single transferrin value. A comprehensive iron status assessment (ferritin, transferrin saturation, soluble transferrin receptor) combined with clinical symptoms is more appropriate. Caveat: High transferrin may indicate iron deficiency but also inflammation or oral contraceptive use. Without context, the value is not interpretable for sleep.